SCHEMBL3377677

SCHEMBL3377677

CSCC(C)NC(=O)c1cccc(OS(=O)(=O)C(F)(F)F)c1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 1/20 0.37
HSD17B10 Q99714 1/20 0.37
POLB P06746 1/20 0.35
ALDH1A1 P00352 2/20 0.34
CXCR2 P25025 1/20 0.34
HTR2A P28223 1/20 0.34
TSPO P30536 1/20 0.34
GPR183 P32249 1/20 0.34
APLNR P35414 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34
DRD2 P14416 2/20 0.33
DRD3 P35462 2/20 0.33
ATM Q13315 1/20 0.33
RAB9A P51151 1/20 0.33
PTPN1 P18031 1/20 0.33
HTR1D P28221 1/20 0.33
DRD4 P21917 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3377672 0.91 DRD2 (0.35) MEN1KMT2AHPGDKDM4EHSD17B10
SCHEMBL3373454 0.90 MEN1 (0.48) MEN1KMT2AHPGDKDM4EHSD17B10
SCHEMBL550872 0.88 MEN1 (0.39) MEN1KMT2AHPGDKDM4EHSD17B10
SCHEMBL3379111 0.87 NPSR1 (0.40) HPGDKDM4EHSD17B10ALDH1A1CXCR2
SCHEMBL3377960 0.87 MEN1 (0.41) MEN1KMT2AHPGDKDM4EHSD17B10
SCHEMBL6227836 0.82 KCNA3 (0.38) MEN1KMT2AHPGDKDM4EPOLB
SCHEMBL3374783 0.81 MEN1 (0.40) MEN1KMT2AHPGDKDM4EPOLB
SCHEMBL3376138 0.81 POLB (0.45) MEN1KMT2AHPGDKDM4EHSD17B10
SCHEMBL3373446 0.81 MEN1 (0.45) MEN1KMT2AHPGDKDM4EHSD17B10
SCHEMBL3377641 0.80 NPSR1 (0.40) RXFP1DRD2DRD3PTPN1HTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517886-B1 NOVEL PHTHALAMIDE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2010-11-10 EP disclosed
US-7132455-B2 Phthalamide derivatives BAYER CROPSCIENCE AG (DE) 2006-11-07 US disclosed
US-20060035967-A1 Novel phthalamide derivatives BAYER INTELLECTUAL PROPERTY GMBH (DE) 2006-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060035967-A1 Novel phthalamide derivatives HDAC1, HDAC2, CRY1 MEN1 1772/4885KMT2A 102/4885HPGD 2293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.